New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
Xiaomin Liu, Huaiqian Xu, Qingshan Geng, Wai-Ho Mak, Fei Ling, Zheng Su, Fang� Yang, Tao Zhang, Jiyan Chen, Jian Wang, Xiuqing Zhang, Xun Xu, Huijue Jia, Zhiwei Zhang, Xiao Liu, Shilong Zhong
This study identifies six new genetic variants associated with major adverse cardiovascular events in ACS patients on dual antiplatelet therapy and develops a predictive classifier for MACE.
The Pharmacogenomics Journal · Jun 22, 2021Peer-reviewedGenetics